NCT06134193 2023-11-18
Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
Clinical Trials
25 trialsNCT06013943 2023-09-15
Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC
Eastern Hepatobiliary Surgery Hospital
Phase 2 Unknown
NCT05681949 2023-08-24
ADBoard
Charite University, Berlin, Germany
Phase NA Unknown
NCT04211168 2023-03-29
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
Peking Union Medical College Hospital
Phase 2 Unknown
NCT05620498 2022-11-17
Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT04362449 2022-07-15
Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration
Imperial College Healthcare NHS Trust
Phase 2 Unknown
NCT04337333 2021-07-21
Two-in-one Covered and Uncovered Metal Stent
Ajou University School of Medicine
Phase NA Unknown
NCT04333927 2020-06-23
ACCORD
Sun Yat-sen University
Phase 2 Unknown
NCT02762227 2020-02-11
The Role of Different Imaging Methods in the Diagnosis of Gallbladder Polyps
RenJi Hospital
Phase NA Unknown
NCT03139487 2020-01-06
PRIORITY
Asan Medical Center
Phase 2 Unknown
NCT02646514 2019-01-28
Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study
Yonsei University
Phase NA Unknown
NCT02659852 2019-01-28
A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction
Yonsei University
Phase NA Unknown
NCT03779035 2018-12-19
AdBTC-1
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT03772132 2018-12-11
Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT03768375 2018-12-07
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT03702491 2018-10-11
Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2 Unknown
NCT03607643 2018-07-31
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Leaf Vertical Inc.
Phase 1/2 Unknown
NCT02836847 2018-05-07
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT03491878 2018-04-09
Three Dimension Laparoscopic Versus Open Surgery for Gallbladder Carcinoma
Tongji Hospital
Phase NA Unknown
NCT02798510 2016-06-22
Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma
Fudan University
Phase 3 Unknown
NCT02662348 2016-01-25
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System
The First Affiliated Hospital with Nanjing Medical University
Phase 1 Unknown
NCT00003296 2013-12-19
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00274885 2011-12-05
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
National Cancer Institute (NCI)
Phase 4 Unknown
NCT01317069 2011-03-17
A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer
Simcere Pharmaceutical Co., Ltd
Phase 2 Unknown
NCT00356161 2006-07-25
HAI Via Interventionally Implanted Port Catheter Systems
Charite University, Berlin, Germany
Phase 2 Unknown